Systemic Lipid Metabolism and Coagulation Pathways

The phrase "Systemic Lipid Metabolism and Coagulation Pathways" refers to the complex and interrelated processes whereby the body regulates both lipid (fat) processing and blood clot formation. Lipid metabolism involves the breakdown, transport, and synthesis of lipids, and is essential for energy storage, membrane synthesis, and signaling. Coagulation pathways, including the intrinsic, extrinsic, and common pathways, are biochemical cascades that produce blood clots by activating clotting factors, leading to the conversion of fibrinogen to fibrin and the stabilization of a hemostatic plug[1][2][3][4][6]. Recent research shows that certain plasma lipids can modulate the activities of clotting factors and influence thrombosis risk, demonstrating cross-talk between these seemingly distinct biological systems[5]. However, "Systemic Lipid Metabolism and Coagulation Pathways" is not a defined molecule, gene, or drug target but identifies two intersecting physiological systems comprised of many validated molecular targets. This entry is not a canonical molecule/receptor or therapeutic target; it represents an ensemble of pathways rather than a single, actionable biological entity. This makes it unsuitable for drug targeting or mapping in structured databases as a discrete entry.

Other names

Lipid metabolism and coagulationLipid–coagulation pathways